Crude | Adjusted† | |||||
---|---|---|---|---|---|---|
Variable | HR | (95% CI) | p-value | HR | (95% CI) | p-value |
Age (every one year) | 1.01 | 1.00–1.02 | 0.028* | 1.01 | 0.99–1.02 | 0.121 |
Sex (male vs. female) | 1.31 | 1.05–1.64 | 0.019* | 1.29 | 1.02–1.64 | 0.034* |
ECOG PS | ||||||
0 | Ref | Ref | ||||
1 | 2.08 | 1.57–2.75 | < 0.001* | 1.80 | 1.33–2.42 | < 0.001* |
≥ 2 | 3.79 | 2.69–5.34 | < 0.001* | 2.82 | 1.94–4.10 | < 0.001* |
Group | ||||||
TC-/PPI- | Ref | Ref | ||||
TC + /PPI- | 0.65 | 0.45–0.93 | 0.019* | 1.07 | 0.73–1.59 | 0.708 |
TC-/PPI + | 1.70 | 1.31–2.20 | < 0.001* | 1.50 | 1.15–1.96 | 0.003* |
TC + /PPI + | 0.99 | 0.70–1.39 | 0.931 | 1.30 | 0.89–1.88 | 0.175 |
Brain metastases | 2.24 | 1.75–2.86 | < 0.001* | 2.11 | 1.62–2.73 | < 0.001* |
Skin rash | 0.25 | 0.19–0.32 | < 0.001* | 0.28 | 0.21–0.37 | < 0.001* |